XML 48 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Quarterly Financial Data
 12 Months Ended
Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data
Note 22 - Quarterly Financial Data
(Unaudited)
2021
1st2nd3rd4thTotal
Net sales$1,025.4 $1,062.9 $1,037.3 $1,007.3 $4,132.9 
Gross profit299.2 302.3 267.9 233.1 1,102.5 
Selling, general and administrative expenses144.5 149.0 140.7 146.3 580.5 
Impairment and restructuring charges4.0 1.3 2.9 0.7 8.9 
Net income (1)
116.0 107.2 91.6 66.7 381.5 
Net income attributable to noncontrolling interests
2.7 2.4 3.5 3.8 12.4 
Net income attributable to The Timken Company113.3 104.8 88.1 62.9 369.1 
Net income per share - Basic:$1.49 $1.38 $1.16 $0.83 $4.86 
Net income per share - Diluted:$1.47 $1.36 $1.14 $0.82 $4.79 
Dividends per share$0.29 $0.30 $0.30 $0.30 $1.19 
2020
1st2nd3rd4thTotal
Net sales$923.4 $803.5 $894.6 $891.7 $3,513.2 
Gross profit278.9 230.3 263.7 237.0 1,009.9 
Selling, general and administrative expenses153.6 111.8 132.7 135.7 533.8 
Impairment and restructuring charges3.6 3.1 12.0 2.5 21.2 
Net income (2)
84.0 61.8 91.3 55.3 292.4 
Net income attributable to noncontrolling interests3.3 (0.1)2.5 2.2 7.9 
Net income attributable to The Timken Company80.7 61.9 88.8 53.1 284.5 
Net income per share - Basic:$1.07 $0.82 $1.18 $0.70 $3.78 
Net income per share - Diluted:$1.06 $0.82 $1.16 $0.69 $3.72 
Dividends per share$0.28 $0.28 $0.28 $0.29 $1.13 
Earnings per share are computed independently for each of the quarters presented; therefore, the sum of the quarterly earnings per share may not equal the total computed for the year.
(1)Net income for the second quarter of 2021 included net actuarial losses of $3.5 million. Net income for the third quarter of 2021 included net actuarial losses of $3.9 million. Net income for the fourth quarter of 2021 included net actuarial gains of $8.0 million and the reversal of tax valuation allowances of $7.8 million.
(2)Net income for the second quarter of 2020 included net actuarial losses of $8.8 million. Net income for the third quarter of 2020 included net actuarial gains of $11.9 million and impairment and restructuring charges of $12.0 million. Net income for the fourth quarter of 2020 included net actuarial losses of $21.6 million.